Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
The stock carries a Zacks Rank #2 (Buy) currently. Boston Scientific is consistently gaining market share within its MedSurg segment. The Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal (GI) and pulmonary treatment options. Particularly, the company is gaining market share with its biliary franchise led by the AXIOS Stent and Delivery System and the hemostasis, single-use imaging and metal stents franchises. Within Urology, Boston Scientific continues to expand its market share globally. The company's stone management franchise is growing well, led by LithoVue Single-Use Digital Flexible Ureteroscope System. Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction on the strength of spinal cord stimulation (SCS), which is driven by its innovative Alpha portfolio with fast therapy in a cognitive suite of digital tools supporting patient activation. Boston Scientific Corporation Pri
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Q'Apel Medical Appoints Jay Hallinan as Chief Commercial Officer [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Co. (NYSE: BSX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Why is Boston Scientific Stock Trading Lower On Wednesday? [Yahoo! Finance]Yahoo! Finance
- ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 [Yahoo! Finance]Yahoo! Finance
- ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024PR Newswire
BSX
Earnings
- 10/23/24 - Beat
BSX
Sec Filings
- 10/23/24 - Form 8-K
- 10/8/24 - Form 4
- 10/8/24 - Form 4
- BSX's page on the SEC website